secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANGIODYNAMICS INC (ANGO)
CIK:        0001275187
Form:       8-K
Filed at:   2023-11-16T23:59:59+00:00
Accession:  0001140361-23-053522
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AngioDynamics shareholders approve amended equity plan and elect directors at annual meeting
--------------------------------------------------------------------------------

- All four board nominees elected with votes ranging from 23.6M to 25.9M for; avg 24.7M for, 1.9M withheld.
- Amended 2020 Equity Incentive Plan approved with 24.1M for and 2.5M against (excl. 5.8M broker non-votes).
- Advisory say-on-pay approved with 24.4M for, 2.2M against; annual frequency vote also passed.
- Ratification of Deloitte & Touche as auditor for FY ending May 31, 2024: 32.4M for, 11K against.
- Company will hold advisory say-on-pay votes annually until next required frequency vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/0001140361-23-053522-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/ef20014806_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-053522

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer